Retrospective assessment of β-d-(1,3)-glucan for presumptive diagnosis of fungal infections

APMIS

Volumn 119, Issue 4-5, 2011, Pages 280-286

  Bellanger, Anne Pauline ^a,b   Grenouillet, Frederic ^b   Henon, Thierry ^b   Skana, Florence ^b   Legrand, Faezeh ^b   Deconinck, Eric ^b,c   Millon, Laurence ^a,b  

^a UNIVERSITÉ DE FRANCHE COMTÉ   (France)

^b UNIVERSITY HOSPITAL OF BESANÇON   (France)

^c INSERM   (France)

Author keywords

d glucan assay; Fungal infection; Invasive aspergillosis

Indexed keywords

BETA 1,3 GLUCAN; GALACTOMANNAN;

ADULT; ARTICLE; CANDIDEMIA; CLINICAL ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; EARLY DIAGNOSIS; FEMALE; FUNGUS IDENTIFICATION; FUSARIOSIS; HUMAN; INVASIVE ASPERGILLOSIS; MALE; MYCOSIS; PNEUMOCYSTOSIS; PRIORITY JOURNAL; RETROSPECTIVE STUDY; ZYGOMYCOSIS;

ASPERGILLOSIS; BETA-GLUCANS; FRANCE; HEMATOLOGIC NEOPLASMS; HUMANS; IMMUNOCOMPROMISED HOST; MANNANS; MYCOSES; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 79954822316     PISSN: 09034641     EISSN: 16000463     Source Type: Journal    
DOI: 10.1111/j.1600-0463.2011.02728.x     Document Type: Article

References (35)

1. Garcia-Vidal C, Upton A, Kirby KA, Marr KA. Epidemiology of invasive mold infections in allogeneic stem cell transplant recipients: biological risk factors for infection according to time after transplantation. Clin Infect Dis 2008;47:1041-50.
2. Pagano L, Caira M, Candoni A, Offidani M, Fianchi L, Martino B, et al. The epidemiology of fungal infections in patients with hematologic malignancies: the SEIFEM-2004 study. Haematologica 2006;91:1068-75.
3. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008;46:1813-21.
4. Cornillet A, Camus C, Nimubona S, Gandemer V, Tattevin P, Belleguic C, et al. Comparison of epidemiological, clinical, and biological features of invasive aspergillosis in neutropenic and nonneutropenic patients: a 6-year survey. Clin Infect Dis 2006;43:577-84.
5. Cornely OA, Maertens J, Winston DJ, Perfect J, Ullmann AJ, Walsh TJ, et al. Posaconazole vs. fluconazole or itraconazole prophylaxis in patients with neutropenia. N Engl J Med 2007;356:348-59.
6. Hossain MA, Miyazaki T, Mitsutake K, Kakeya H, Yamamoto Y, Yanagihara K, et al. Comparison between Wako-WB003 and Fungitec G tests for detection of (1-->3)-beta-d-glucan in systemic mycosis. J Clin Lab Anal 1997;11:73-7.
7. Tamura H, Arimoto Y, Tanaka S, Yoshida M, Obayashi T, Kawai T. Automated kinetic assay for endotoxin and (1-->3)-beta-d-glucan in human blood. Clin Chim Acta 1994;226:109-12.
8. Odabasi Z, Mattiuzzi G, Estey E, Kantarjian H, Saeki F, Ridge RJ, et al. Beta-d-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis 2004;39:199-205.
9. Ostrosky-Zeichner L, Alexander BD, Kett DH, Vazquez J, Pappas PG, Saeki F, et al. Multicenter clinical evaluation of the (1-->3) beta-d-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis 2005;41:654-9.
10. Pickering JW, Sant HW, Bowles CA, Roberts WL, Woods GL. Evaluation of a (1-->3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2005;43:5957-62.
11. Persat F, Ranque S, Derouin F, Michel-Nguyen A, Picot S, Sulahian A. Contribution of the (1-->3)-beta-d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 2008;46:1009-13.
12. Del Bono V, Mularoni A, Furfaro E, Delfino E, Rosasco L, Miletich F, et al. Clinical evaluation of a (1, 3)-beta-d-glucan assay for presumptive diagnosis of Pneumocystis jiroveci pneumonia in immunocompromised patients. Clin Vaccine Immunol 2009;16:1524-6.
13. Tasaka S, Hasegawa N, Kobayashi S, Yamada W, Nishimura T, Takeuchi T, et al. Serum indicators for the diagnosis of pneumocystis pneumonia. Chest 2007;131:1173-80.
14. Del Palacio A, Cuetara MS, Llenas-Garcia J, Alvarez ME, Chaves F, Pulido F, et al. Serum (1-->3)-β-d-glucan assay for the diagnosis of Pneumocystis jiroveci pneumonia. Clin Vaccine Immunol 2010;17:202-3.
15. Ikemura K, Ikegami K, Shimazu T, Yoshioka T, Sugimoto T. False-positive result in Limulus test caused by Limulus amebocyte lysate-reactive material in immunoglobulin products. J Clin Microbiol 1989;27:1965-8.
16. Racil Z, Kocmanova I, Lengerova M, Weinbergerova B, Buresova L, Toskova M, et al. Difficulties in using 1, 3-beta-d glucan as the screening test for the early diagnosis of invasive fungal diseases in patients with hematological malignancies - high frequency of false positive results and their analysis. J Med Microbiol 2010;59:1016-22.
17. Marr KA, Balajee SA, McLaughlin L, Tabouret M, Bentsen C, Walsh TJ. Detection of galactomannan antigenemia by enzyme immunoassay for the diagnosis of invasive aspergillosis: variables that affect performance. J Infect Dis 2004;190:641-9.
18. Mohr JF, Sims C, Paetznick V, Rodriguez J, Finkelman MA, Rex JH, et al. Prospective survey of (1-->3)-β-d-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol 2011;49:58-61.
19. Ostrosky-Zeichner L, Kullberg BJ, Bow EJ, Hadley S, Leon C, Nucci M, et al. Early treatment of candidemia in adults: a review. Med Mycol 2011;49:113-20.
20. Miyazaki T, Kohno S, Mitsutake K, Maesaki S, Tanaka K, Ishikawa N, et al. Plasma (1-->3)-beta-d-glucan and fungal antigenemia in patients with candidemia, aspergillosis, and cryptococcosis. J Clin Microbiol 1995;33:3115-18.
21. Odabasi Z, Paetznick VL, Rodriguez JR, Chen E, McGinnis MR, Ostrosky-Zeichner L. Differences in beta-glucan levels in culture supernatants of a variety of fungi. Med Mycol 2006;44:267-72.
22. Miyazaki T, Kohno S, Mitsutake K, Maesaki S, Tanaka K, Hara K. (1-->3)-beta-d-glucan in culture fluid of fungi activates factor G, a limulus coagulation factor. J Clin Lab Anal 1995;9:334-9.
23. Obayashi T, Negishi K, Suzuki T, Funata N. Reappraisal of the serum (1-->3)-beta-d-glucan assay for the diagnosis of invasive fungal infections - a study based on autopsy cases from 6years. Clin Infect Dis 2008;46:1864-70.
24. Senn L, Robinson JO, Schmidt S, Knaup M, Asahi N, Satomura S, et al. 1, 3-beta-d-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis 2008;46:878-85.
25. Ansorg R, van den Boom R, Rath PM. Detection of Aspergillus galactomannan antigen in foods and antibiotics. Mycoses 1997;40:353-7.
26. Maertens J, Verhaegen J, Lagrou K, Van Eldere J, Boogaerts M. Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation. Blood 2001;97:1604-10.
27. Viscoli C, Machetti M, Cappellano P, Bucci B, Bruzzi P, Van Lint MT, et al. False-positive galactomannan platelia Aspergillus test results for patients receiving piperacillin-tazobactam. Clin Infect Dis 2004;38:913-16.
28. Walsh TJ, Shoham S, Petraitiene R, Sein T, Schaufele R, Kelaher A, et al. Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interaction. J Clin Microbiol 2004;42:4744-8.
29. Millon L, Grenouillet F, Crouzet J, Larosa F, Loewert S, Bellanger AP, et al. False-positive Aspergillus real-time PCR assay due to a nutritional supplement in a bone marrow transplant recipient with GVH disease. Med Mycol 2010;48:661-4.
30. Huang YT, Hung CC, Hsueh PR. Aspergillus galactomannan antigenemia in penicilliosis marneffei. Aids 2007;21:1990-1.
31. Narreddy S, Chandrasekar PH. False-positive Aspergillus galactomannan (GM) assay in histoplasmosis. J Infect 2008;56:80-1.
32. Thornton CR. Detection of invasive aspergillosis. Adv Appl Microbiol 2010;70:187-216.
33. Millon L, Piarroux R, Deconinck E, Bulabois CE, Grenouillet F, Rohrlich P, et al. Use of real-time PCR to process the first galactomannan-positive serum sample in diagnosing invasive aspergillosis. J Clin Microbiol 2005;43:5097-101.
34. White PL, Bretagne S, Klingspor L, Melchers WJ, McCulloch E, Schulz B, et al. Aspergillus PCR: one step closer to standardization. J Clin Microbiol 2010;48:1231-40.
35. Morton CO, Loeffler J, De Luca A, Frost S, Kenny C, Duval S, et al. Dynamics of extracellular release of Aspergillus fumigatus DNA and galactomannan during growth in blood and serum. J Med Microbiol 2010;59:408-13.